首页> 美国卫生研究院文献>ESC Heart Failure >Plasma calcidiol calcitriol and parathyroid hormone and risk of new onset heart failure in a population‐based cohort study
【2h】

Plasma calcidiol calcitriol and parathyroid hormone and risk of new onset heart failure in a population‐based cohort study

机译:一项基于人群的队列研究显示血浆降钙素骨化三醇和甲状旁腺激素与新发心力衰竭的风险

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHeart failure (HF) is a major problem in the Western world, with increasing prevalence and incidence. Because HF cannot be cured, prevention of HF is of utter importance. Calcidiol, calcitriol, and parathyroid hormone (PTH) have been identified as risk factors for cardiovascular disease. However, their association with new onset HF remains to be established. We investigated whether calcidiol, calcitriol, and PTH could be used to identify those subjects at risk for new onset HF, and if they had additive predictive value over established risk predictors like N‐terminal‐pro Brain‐type natriuretic peptide and highly sensitive Troponin‐T.
机译:背景随着越来越多的患病率和发病率,心力衰竭(HF)在西方世界是一个主要问题。由于HF无法固化,因此预防HF非常重要。骨化二醇,骨化三醇和甲状旁腺激素(PTH)已被确定为心血管疾病的危险因素。但是,它们与新发HF的关系尚待确定。我们调查了降钙糖,降钙三醇和PTH是否可用于识别那些有新发HF风险的受试者,以及他们是否比既定的风险预测因子(如N-末端脑型利尿钠肽和高敏感性肌钙蛋白- T.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号